Results 131 to 140 of about 18,364 (184)

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study. [PDF]

Front Pharmacol
Moloney BD, Forsyth A, Sumner RL, Glover SC, Hoeh NR, Sundram F, Cavadino A, Muthukumaraswamy S, Lin JC.   +8 more
europepmc   +1 more source

Relationship between extended-release buprenorphine adherence and reduced risk of return to use in patients with opioid use disorder: A retrospective claims data analysis. [PDF]

Drug Alcohol Depend Rep
Jerry M, Venkat D, Flynn C, Tran AT, Abdel-Sattar M, Mullen W, Lane C.   +6 more
europepmc   +1 more source

Synergistic effects of levo-tetrahydropalmatine and low-dose naltrexone on nicotine conditioned place preference in mice: a dual-target strategy based on dopamine and opioid systems. [PDF]

Front Pharmacol
Feng K, Zhao Y, Liu L, Kang S, Yu M, Sy SKB, Lv Z, Yan M.   +7 more
europepmc   +1 more source

Trends and Outcomes of Alcoholic Acute Pancreatitis in Patients with Alcohol Use Disorder Treated with Naltrexone in the United States: Before and After the COVID-19 Pandemic. [PDF]

Dig Dis Sci
Koo TH, Malik A, Sheriff MZ, Chowdhary R, Lindsey A.   +4 more
europepmc   +1 more source

Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. [PDF]

Pharmacoepidemiol Drug Saf
Ross RK, Butler AM, Seamans MJ, Williams AR, Samples H, Rudolph KE.   +5 more
europepmc   +1 more source

Letter: Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease-Authors' Reply. [PDF]

Aliment Pharmacol Ther
Díaz LA, Loomba R.
europepmc   +1 more source

Naltrexone/Bupropion/Mirtazapine Triple Therapy for Treatment-Resistant Methamphetamine Use Disorder: A Case Series. [PDF]

Cureus
Shariatzadeh N, Wakhlu S.
europepmc   +1 more source

Corrigendum: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. [PDF]

Korean J Pain
Hariyanto TI, Vatvani AD, Patel P, Yanto TA.   +3 more
europepmc   +1 more source

Synthesis and evaluation of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors. [PDF]

RSC Med Chem
Ostovar M, Olsen K, Cami-Kobeci G, Traynor JR, Jeramaz L, Kirton SB, Husbands SM.   +6 more
europepmc   +1 more source

Real-World Effectiveness and Tolerability of Low Dose Naltrexone to Treat Chronic Pain: A Retrospective Cohort Study of One Pain Physician's Practice. [PDF]

J Pain Res
Aalto H, Paul S, McEwen V.
europepmc   +1 more source